Detection of carriers of cerebrotendinous xanthomatosis
- 1 July 1986
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 158 (2) , 179-185
- https://doi.org/10.1016/0009-8981(86)90234-2
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosisClinica Chimica Acta; International Journal of Clinical Chemistry, 1985
- Long-Term Treatment of Cerebrotendinous Xanthomatosis with Chenodeoxycholic AcidNew England Journal of Medicine, 1984
- Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatmentClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis)Clinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatographyClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Cerebrotendinous cholestanolosis in relation to other cerebral xanthomatosesClinical Neurology and Neurosurgery, 1976
- Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous XanthomatosisBiochemical Medicine, 1975
- A Biochemical Abnormality in Cerebrotendinous Xanthomatosis IMPAIRMENT OF BILE ACID BIOSYNTHESIS ASSOCIATED WITH INCOMPLETE DEGRADATION OF THE CHOLESTEROL SIDE CHAINJournal of Clinical Investigation, 1974